Legis Daily

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

USA116th CongressS-2477| Senate 
| Updated: 9/12/2019
Kirsten E. Gillibrand

Kirsten E. Gillibrand

Democratic Senator

New York

Cosponsors (5)
Charles E. Schumer (Democratic)Chris Van Hollen (Democratic)Debbie Stabenow (Democratic)Cory A. Booker (Democratic)Susan M. Collins (Republican)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 25, 2019

Latest Companion Bill Action

HR 116-3446
Referred to the Subcommittee on Health.
Sep 12, 2019
Introduced in Senate
Sep 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • June 25, 2019

    Latest Companion Bill Action

    HR 116-3446
    Referred to the Subcommittee on Health.
  • September 12, 2019
    Introduced in Senate
  • September 12, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • HR 116-3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

USA116th CongressS-2477| Senate 
| Updated: 9/12/2019
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 25, 2019

Latest Companion Bill Action

HR 116-3446
Referred to the Subcommittee on Health.
Sep 12, 2019
Introduced in Senate
Sep 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • June 25, 2019

    Latest Companion Bill Action

    HR 116-3446
    Referred to the Subcommittee on Health.
  • September 12, 2019
    Introduced in Senate
  • September 12, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Kirsten E. Gillibrand

Kirsten E. Gillibrand

Democratic Senator

New York

Cosponsors (5)
Charles E. Schumer (Democratic)Chris Van Hollen (Democratic)Debbie Stabenow (Democratic)Cory A. Booker (Democratic)Susan M. Collins (Republican)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development